Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News VALEANT PHARMACEUTICALS INTL INC T.VRX

Healthcare Drug Manufacturers - Specialty & Generic
"Valeant Pharmaceuticals is a global specialty pharmaceutical firm with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets. The firm also has a branded generics business that operates primarily in Latin America, Eastern Europe, and Asia."

Recent & Breaking News (TSX:VRX)

Valeant Appoints Louis W. Yu, Ph.D. As Chief Quality Officer

Canada NewsWire October 6, 2016

Valeant Appoints Louis W. Yu, Ph.D. As Chief Quality Officer

PR Newswire October 6, 2016

Ariad Pharmaceuticals Raises Cancer Drug Price For The 4th Time This Year

Benzinga.com  October 5, 2016

Pharming Reports on Extraordinary General Meeting of Shareholders

PR Newswire Europe Non Regulatory October 5, 2016

Apple trade offers a 5% return in 44 days, or find similar option trades on Valeant Pharmaceuticals, Sears Holdings, The Hartford Financial Services Group Inc., and Salesforce.com

PR Newswire October 5, 2016

The Street Is Underestimating Valeant's Potential Downside From Legal Woes

Benzinga.com  October 3, 2016

Pharming Reports on Financial Results for the First Eight Months of 2016

PR Newswire Europe Non Regulatory October 3, 2016

Valeant Comments On Discount And Rebate Program For Nitropress And Isuprel

Canada NewsWire September 16, 2016

18 Biggest Mid-Day Gainers For Wednesday

Benzinga.com  September 7, 2016

22 Stocks Moving In Wednesday's Pre-Market Session

Benzinga.com  September 7, 2016

Valeant And Progenics Announce The U.S. Commercial Launch Of FDA-Approved Relistor® Tablets

Canada NewsWire September 6, 2016

Mid-Morning Market Update: Markets Open Higher; Lululemon Sales Miss Views

Benzinga.com  September 2, 2016

Valeant Pharmaceuticals To Participate In September Healthcare Conferences

Canada NewsWire August 30, 2016

Valeant Pharmaceuticals To Participate In September Healthcare Conferences

PR Newswire August 30, 2016

Orexigen Shares Up 14% After Commercialization, Distribution Deal With Valeant Canada

Benzinga.com  August 30, 2016

Valeant Being Sued In NY Federal Court Over Alleged Overcharges

Benzinga.com  August 29, 2016

Drug Price Hike Concerns Spill Over Into Other Pharma Stocks

Benzinga.com  August 24, 2016

Valeant Pharmaceuticals trade offers a 17% return in 206 days, or find similar option trades on The Blackstone Group, Best Buy Inc., Northrup Grumman Corporation, and Suncor Energy

PR Newswire August 23, 2016

Pharming Convene an Extraordinary General Meeting of Shareholders

PR Newswire Europe Non Regulatory August 23, 2016

Mid-Afternoon Market Update: CIFC Rises Following Acquisition News; Marathon Oil Shares Slide

Benzinga.com  August 22, 2016